New India Assurance, the publicly owned general insurance giant, has launched a global mediclaim policy called, 'New India Global Mediclaim Policy', that will cover the hospitalisation expenses incurred by a customer, for treatments like cancer, neuro-surgery, heart surgery, organ transplant and bone marrow transplant in hospitals outside of India.
The Critical Illness policy has two plans: one that covers hospitalization in medical centers located in Asian countries, and the second which covers all of the same illnesses for hospitalisation in medical centres world-wide. The former has a lifetime medical cover of $1 million, whereas the latter has a lifetime medical